Block & Leviton Tapped To Lead Biopharma Stock-Drop Suit
Block & Leviton LLP will represent a proposed class of shareholders in a suit in California federal court alleging drug developer Gossamer Bio Inc. violated federal securities laws by misleading investors...To view the full article, register now.
Already a subscriber? Click here to view full article